BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9149115)

  • 1. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity.
    Soni KB; Lahiri M; Chackradeo P; Bhide SV; Kuttan R
    Cancer Lett; 1997 May; 115(2):129-33. PubMed ID: 9149115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM; Iatropoulos MJ
    Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of aflatoxin induced liver damage by turmeric and curcumin.
    Soni KB; Rajan A; Kuttan R
    Cancer Lett; 1992 Sep; 66(2):115-21. PubMed ID: 1394115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism.
    Gradelet S; Le Bon AM; Bergès R; Suschetet M; Astorg P
    Carcinogenesis; 1998 Mar; 19(3):403-11. PubMed ID: 9525273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenicity an carcinogenicity of aflatoxin AFB1].
    Pierzynowska J; Grzesiuk E
    Postepy Biochem; 1999; 45(4):313-9. PubMed ID: 10786375
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea.
    Qin G; Gopalan-Kriczky P; Su J; Ning Y; Lotlikar PD
    Cancer Lett; 1997 Jan; 112(2):149-54. PubMed ID: 9066721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of ellagic acid on the direct-acting mutagenicity of aflatoxin B1 in the Salmonella microsuspension assay.
    Loarca-Piña G; Kuzmicky PA; de Mejía EG; Kado NY
    Mutat Res; 1998 Feb; 398(1-2):183-7. PubMed ID: 9626978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
    Williams GM; Tanaka T; Maeura Y
    Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers.
    Manson MM; Hudson EA; Ball HW; Barrett MC; Clark HL; Judah DJ; Verschoyle RD; Neal GE
    Carcinogenesis; 1998 Oct; 19(10):1829-36. PubMed ID: 9806166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protection against synergistic hepatocarcinogenesis of hepatitis B virus expression and aflatoxin B1 by antioxidant 2(3)-tert-4 -hydroxyanisole (BHA) in HBV large envelope transgenic mice].
    Wang J; Wang L; Lin S
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):94-7. PubMed ID: 11864462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic.
    Guyonnet D; Belloir C; Suschetet M; Siess MH; Le Bon AM
    Carcinogenesis; 2002 Aug; 23(8):1335-41. PubMed ID: 12151352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved.
    Liu J; Yang CF; Wasser S; Shen HM; Tan CE; Ong CN
    Life Sci; 2001 Jun; 69(3):309-26. PubMed ID: 11441922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia.
    Shepherd AG; Manson MM; Ball HW; McLellan LI
    Carcinogenesis; 2000 Oct; 21(10):1827-34. PubMed ID: 11023540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.
    Hayes JD; McLeod R; Ellis EM; Pulford DJ; Ireland LS; McLellan LI; Judah DJ; Manson MM; Neal GE
    IARC Sci Publ; 1996; (139):175-87. PubMed ID: 8923030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives.
    Williams GM; Iatropoulos MJ; Whysner J
    Food Chem Toxicol; 1999; 37(9-10):1027-38. PubMed ID: 10541460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of soybean saponins and major antioxidants against aflatoxin B1-induced mutagenicity and DNA-adduct formation.
    Jun HS; Kim SE; Sung MK
    J Med Food; 2002; 5(4):235-40. PubMed ID: 12639399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1.
    Reen RK; Wiebel FJ; Singh J
    J Ethnopharmacol; 1997 Nov; 58(3):165-73. PubMed ID: 9421252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
    Guarisco JA; Hall JO; Coulombe RA
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin.
    Firdous AP; Sindhu ER; Ramnath V; Kuttan R
    Asian Pac J Cancer Prev; 2010; 11(6):1795-800. PubMed ID: 21338235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the mutagenicity of aflatoxin B1 and N-methyl-N'-nitro-N-nitrosoguanidine by certain phenolic compounds.
    Francis AR; Shetty TK; Bhattacharya RK
    Cancer Lett; 1989 Jun; 45(3):177-82. PubMed ID: 2499416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.